Therapy guide · medical education
Rosacea: the full therapy pathway
Why the first move is taking products away rather than adding them, what prescriptions actually reach, and the honest limit — no cream on earth removes a visible vessel.
Before anything else
Not everyone should start at the bottom of this pathway. These presentations are reasons to
see a clinician without waiting out an over-the-counter trial first.
- Any change in vision, eye pain, or light sensitivity Seek care quickly
Ocular rosacea can involve the cornea, and corneal disease is the one part of this condition capable of causing permanent damage. Blurring, pain or new sensitivity to light is a same-day question for a doctor or an eye casualty department, not something to raise at a routine dermatology appointment in six weeks.
- Sudden severe facial swelling with fever or feeling unwell Seek care quickly
A face that becomes hot, swollen and painful over hours, particularly with fever, is more likely to be an infection such as erysipelas or cellulitis than a rosacea flare. That needs urgent assessment and usually antibiotics.
- Flushing with diarrhoea, wheezing, palpitations or fainting See a dermatologist soon
Flushing that comes with symptoms elsewhere in the body is a different investigation. It is rarely anything sinister, but it is not a skin question and answering it with a skincare routine wastes the time it would take to answer it properly.
- A red patch that is scaly, crusted, bleeds, or will not heal See a dermatologist soon
Chronically sun-exposed central facial skin is where skin cancers appear, and an early one can hide comfortably inside a background of rosacea redness. A single area behaving differently from everything around it — especially one that bleeds or scabs repeatedly — needs a clinician's eye.
- Rosacea that flares fiercely every time a facial steroid cream is stopped Worth a clinician visit
That pattern suggests steroid dependence, and continuing is what makes it worse. Coming off requires a plan and usually a bridging treatment, which is a supervised process rather than a matter of willpower.
Where are you on this map?
Rosacea is scored by which features are present rather than by a subtype, so a handful of questions places most people on one of the four routes above. Answers stay in this browser and are never sent anywhere.
Seven questions, none of them about your identity and none of them required. The result names a route and a position on it, then filters the page to show that column — everything else stays available behind a single button.
One thing to be clear about. This places you on a map; it does not tell you what you have. Several conditions produce a red face and two of them are treated in opposite directions, so a result here is a starting point for a conversation rather than a substitute for one.
What this looks like
Rosacea used to be divided into four subtypes, and people were told they had 'subtype 1' or 'subtype 2' as though the categories were doors you walked through in order. That framework has been formally retired. Current international consensus scores rosacea by phenotype — by which features are actually present — because in practice people accumulate features rather than progressing through stages, and the subtype label kept implying an escalation that most people never experience. What follows is therefore a description of what is present, not a prediction of what comes next.
Flushing without fixed redness
The face reddens dramatically and then returns to normal. Nothing is visibly wrong between episodes.
What it looks like: Sudden heat and colour across the cheeks, nose and forehead, lasting minutes to an hour, provoked by something identifiable often enough that most people can name at least one trigger. This is the earliest recognisable pattern and the one most often dismissed as a complexion quirk.
Fixed centrofacial redness
The redness no longer fully clears. There is a background level that is simply there, with flushes on top of it.
What it looks like: Steady colour over the central face that intensifies periodically. Thread veins are often visible on close inspection. This is the presentation international consensus treats as diagnostic on its own, and the point at which the vascular side has become a resting state rather than an event.
Papules and pustules
Inflamed bumps and pustules on a red background, without the blackheads and whiteheads acne produces.
What it looks like: Domed red bumps and pus-topped spots concentrated centrally, often in crops, on skin that is already coloured. The absence of comedones is the tell that separates this from acne, and it is the feature that responds best and fastest to treatment.
Thickening and phyma
The skin itself is remodelling — thickening, with enlarged pores and an irregular surface, most often on the nose.
What it looks like: A firm, coarse, sometimes bulbous change in contour that does not go down when the redness settles. Early thickening is subtle and reversible-ish with medical treatment; established phyma is a structural change that needs a physical solution.
Three things that change the plan regardless of severity
Eye involvement
Somewhere around half of people with rosacea have ocular involvement, and it frequently precedes anything on the skin — which means it is routinely attributed to screens, allergies or dry air for years. Grittiness, burning, redness of the lid margins and recurrent styes are the pattern. It matters because it is the one component of rosacea that can threaten sight if it reaches the cornea, and because it does not respond to the creams that fix the face.
Pregnant, breastfeeding, or planning to be
Several mainstays come off the table: oral tetracyclines are avoided outright, and topical retinoids and isotretinoin are contraindicated. Azelaic acid is generally considered compatible and becomes disproportionately useful. Rosacea itself often behaves unpredictably in pregnancy, improving for some and flaring for others, so a plan made in the first trimester may not be the plan by the third.
Richer skin tones
Rosacea is substantially under-diagnosed in deeper skin, because the diagnostic feature everyone is taught to look for is redness — and erythema reads as a warm dusky or violaceous tone rather than pink on brown and black skin. People are frequently told they do not have rosacea when they do, and the delay is often measured in years. Warmth, swelling, burning, and a papular pattern without comedones are the more reliable signals here than colour alone.
Seborrhoeic dermatitis at the same time
The two overlap constantly, and each is treated in a direction the other dislikes. Greasy flaking in the brows, beside the nose and at the hairline points to seborrhoeic dermatitis sitting on top of rosacea; treating only one of them is the usual reason a sensible-looking plan half-works.
Topical steroids used on the face
Steroids reliably calm a red face and then reliably make it worse — producing a steroid-induced rosacea that flares fiercely each time the cream is stopped, which drives people back to using it. Breaking that loop is a supervised job and is one of the more common reasons a rosacea appointment is difficult.
What else it could be
- Seborrhoeic dermatitis — Greasy yellowish scale in the eyebrows, the folds beside the nose, and the scalp. It coexists with rosacea often enough that finding it does not rule rosacea out.
- Acne vulgaris — Blackheads and whiteheads. Rosacea does not produce comedones, and that single distinction resolves most of the confusion between the two — including why acne treatments so often make rosacea worse.
- Lupus (malar rash) — A butterfly rash that characteristically spares the nasolabial folds, where rosacea characteristically does not, and which usually comes with symptoms beyond the skin — joints, fatigue, photosensitivity.
- Contact or irritant dermatitis — Redness with itch and scale that maps to where a product was applied, and that settles when it is stopped. Rosacea burns and stings more than it itches.
- Carcinoid flushing and menopausal flushing — Flushing that involves more than the face, or comes with diarrhoea, wheezing or palpitations, is a different investigation entirely and belongs with a doctor rather than a skincare routine.
The distinction worth carrying to an appointment is comedones — blackheads and whiteheads. Their presence points towards acne, their absence towards rosacea, and the two conditions are treated in nearly opposite directions. People who have spent a year on an acne routine wondering why their face keeps getting angrier are usually people whose skin never had a single blackhead in it.
Why it happens
Rosacea is a disorder of the face's plumbing and its alarm system, not of its pores. Two systems have become over-reactive at once: the blood vessels, which dilate too readily and take too long to settle, and the innate immune system, which produces abnormal amounts of a peptide called cathelicidin and processes it into inflammatory fragments. Add a mite — Demodex folliculorum, which lives on nearly everyone but sits at much higher densities on rosacea skin — and a barrier that has usually been thinned by years of well-meaning scrubbing, and the picture is a face that flushes at nothing, stays flushed longer each time, and eventually stops going back to baseline. That last part is why early rosacea and established rosacea behave so differently: what starts as a reaction becomes a resting state.
Anyone with facial redness that has stopped being occasional, with bumps that look like acne but never come to a head, with a nose or cheeks that feel like they are thickening, or with eyes that have been gritty for months while nobody connected the two. It is also for the large group of people who have been treating rosacea as acne for years — with scrubs, foaming washes and benzoyl peroxide — and getting steadily worse while doing everything the internet told them.
Orientation, not diagnosis. This page helps you orient — it is not a diagnosis. Several conditions produce a red face: seborrhoeic dermatitis, which often sits alongside rosacea rather than instead of it; contact allergy; lupus, whose butterfly rash spares the folds beside the nose where rosacea does not; and the flushing of menopause or of certain medicines. A clinician distinguishes these in minutes and it is worth the appointment, because two of them are treated in opposite directions.
No prescription needed for any of this The over-the-counter pathway
The over-the-counter tier in rosacea is unusual because its most valuable move is subtraction. Most people arriving at this page are running a routine that is quietly provoking the thing they are trying to calm — a foaming wash that strips, an exfoliant used because the skin feels rough, a vitamin C serum that stings and is being persevered with, a fragranced moisturiser applied to skin whose barrier stopped coping some time ago. Take those away and a meaningful proportion of the redness goes with them, before a single active is introduced. What remains after that is genuinely treatable over the counter: azelaic acid has real evidence in inflammatory rosacea, niacinamide and barrier repair address the leakiness underneath, and daily photoprotection is the single best-supported preventive measure there is, because ultraviolet exposure is the most consistently reported trigger across populations.
Appropriate for: Flushing and mild fixed redness, mild papules and pustules, and every other presentation as the foundation underneath whatever is prescribed. Nothing above this tier replaces it — the prescriptions work markedly better on skin that is not simultaneously being irritated, and the commonest reason a prescription underperforms is that the routine around it never changed.
This chart runs backwards compared with the rest of the site. It does not start by adding a product — it starts by removing several, because on rosacea skin the routine is very often part of the problem. Work down it in order; each step has a readiness question rather than a schedule, and nothing here needs to be bought before the step that calls for it.
The failure mode: treating an inflamed face like a dirty one
Almost everyone arrives at rosacea through acne logic — deep cleansing, exfoliating the rough patches, drying out the bumps, and persevering through the sting because it feels like something working. On rosacea skin every one of those moves increases permeability, and a more permeable barrier reacts to more things, more strongly. The result is a routine that produces exactly the redness it was bought to fix, and a person who concludes their skin is simply impossible. The way out is to take things away first and add back one item at a time — which is slower than it sounds and more effective than it looks.
Four rules that matter more than any product you buy
- One new thing at a time, with at least two weeks between introductions. Rosacea skin reacts often enough that adding two products together makes it impossible to know which one to blame.
- Lukewarm water, always, and pat rather than rub. Heat is an independent trigger from anything in a bottle, and a hot shower on the face undoes a good deal of careful product selection.
- Stinging is information, not a rite of passage. A product that stings on day one and less by day ten is settling in; one that stings more each week is doing damage, and persevering with it is the single most common self-inflicted setback in rosacea.
- Patch test anything new for several days on the inner forearm or beside the ear before it goes near the central face. It costs a week and saves the flare that sets everything back a month.
Answer as you go and the chart tracks where you are. Nothing is sent anywhere.
- Week 0You are here
Take things away
Stop provoking the skin, so that everything after this is measuring treatment rather than measuring damage.
What this step involves
Morning
- Stop the exfoliants entirely Scrubs, cleansing brushes, konjac sponges, glycolic and salicylic toners, enzyme powders. All of them, not a reduced frequency — the goal is a clean baseline, and a weekly scrub is still a weekly setback.
- Retire the foaming or stripping wash If the skin feels tight, squeaky or 'clean' after washing, the wash is too strong for this face. That feeling is the barrier reporting a loss, not a job well done.
- Pause the actives Vitamin C, retinol, acids, and anything marketed as brightening or resurfacing. Some of these may come back later; none of them should be running while a baseline is being established.
Evening
- Cut the fragrance Including essential oils and the botanical extracts sold as calming — lavender, peppermint, menthol, camphor, witch hazel and citrus oils are among the more reliable stingers on reactive facial skin.
- Turn the water temperature down Lukewarm to wash, and keep the shower off the face where you can. Heat provokes flushing independently of everything else and is the trigger people most often overlook because it does not come in a bottle.
Why this step: Rosacea skin is measurably more permeable than unaffected skin and loses water faster through the barrier. Every stripping or abrasive step widens that gap, which is why a routine that another person tolerates without comment can keep a rosacea flare running indefinitely. Removing the provocation is the only intervention here that works immediately and costs nothing.
What's normal: The first week can feel worse — skin that has been regularly exfoliated often looks duller and rougher when that stops, and it is easy to read that as the routine failing. Give it a fortnight before drawing conclusions.
Ready for the next step?
Is the routine down to cleansing and moisturising only, with nothing active running?
Yes — it is stripped back: Good. The baseline is set. Go to step 2 ↓ Go to step 1 ↓
Not yet: Stay here until it is. Every step below assumes a quiet baseline, and starting them early is what makes the results unreadable.
- Weeks 1–2You are here
Three products, twice a day
Rebuild the barrier so the skin stops reacting to everything, which is what makes any active tolerable later.
What this step involves
Morning
- A non-foaming, fragrance-free cleanser Cream, milk or lotion textures, used with lukewarm water and fingertips. On lighter days, rinsing with water alone in the morning is a legitimate option rather than a shortcut. Browse all cleansers →
- A simple barrier moisturiser Ceramides, glycerin or niacinamide in the shortest ingredient list you can find. Applied to slightly damp skin it works better and stings less. Browse all moisturizers →
Evening
- The same cleanser, the same moisturiser Deliberately identical to the morning. Variety is not a virtue at this stage — the point is a routine so unremarkable that any reaction has an obvious cause. Browse all moisturizers →
Why this step: The barrier is the part of rosacea that skincare can genuinely repair. Restoring the lipids the skin is short of reduces water loss and permeability, and a less permeable barrier is a less reactive one — which lowers baseline redness and, more importantly, buys the tolerance that the active in step 4 will require.
What's normal: Nothing here should sting at all. A moisturiser that stings on intact skin is the wrong moisturiser, and the answer is to change it rather than to get used to it.
Ready for the next step?
Has the skin gone two weeks without a new sting, burn or reaction from the routine itself?
Yes — it has settled: The barrier is doing its job. Go to step 3 ↓ Go to step 2 ↓
No, something is still stinging: Work out which of the two products it is by dropping one for a week. Do not move on with an unidentified stinger in the routine — it will be blamed on the active later.
- Weeks 2–3You are here
Make sunscreen a habit before it is a therapy
Establish daily photoprotection while the routine is still simple enough that a badly-tolerated sunscreen is easy to spot.
What this step involves
Morning
- A mineral sunscreen, SPF 30 or higher Zinc oxide or titanium dioxide bases tend to sting less on reactive skin and do not convert light to heat within it. A green-tinted version also cancels some of the visible redness, which is cosmetic but genuinely welcome. Browse all sunscreens →
- Applied before anything else goes on top A pea-sized amount for the face is roughly the right quantity, spread rather than rubbed in hard. Give it a minute to set before makeup, which stops the pilling that makes people abandon it.
Why this step: Sun exposure is the trigger reported most consistently across rosacea populations, and ultraviolet light drives the vascular and inflammatory changes underneath the condition over years. This is the step whose benefit you cannot feel and cannot see, which is exactly why it is placed here — established as a habit while the routine is quiet, rather than added later when it will be competing for tolerance with an active.
What's normal: Sunscreen is where tolerability beats theory. A chemical filter you will wear daily protects more skin than a mineral one that stings and stays in the drawer.
Ready for the next step?
Is sunscreen going on most mornings without a fight?
Yes — it is part of the routine: That is the foundation complete. Go to step 4 ↓ Go to step 3 ↓
No — it stings, pills or gets skipped: Try a different filter type or texture before adding anything else. A sunscreen that does not get worn is a problem worth solving on its own, and solving it now is easier than solving it alongside an active.
- Week 4 onwardYou are here
Introduce the one active
Add azelaic acid slowly enough that the skin accepts it, since abandonment through irritation is the usual reason it appears not to work.
What this step involves
Morning
- Moisturiser first if the skin is reactive Applying the moisturiser before the active deliberately blunts it. Slightly less active reaches the skin, and slightly less is considerably better than none because the tube was abandoned in week two. Browse all moisturizers →
Evening
- Azelaic acid 10%, every third night to start A thin layer over the central face. Build to alternate nights after a fortnight if it is comfortable, then nightly, then twice daily if the skin is happy there. Plenty of people do well at alternate nights and never go further. Browse all azelaic acid products →
- Moisturiser over the top Applied a few minutes later. This is not undoing the active — it is what keeps the barrier intact while the active does its work. Browse all moisturizers →
Why this step: Azelaic acid interferes with the inflammatory signalling that drives rosacea rather than masking the colour, and it is the only over-the-counter active here that is the same molecule as its prescription counterpart. The staircase pattern exists because the first fortnight is the entire barrier to using it — the tingle is expected, it settles, and people who ramp up gently stay on it while people who start twice-daily generally do not.
What's normal: A warm prickle for ten or fifteen minutes after applying is normal and fades over the first two to three weeks. Burning that lasts an hour, spreads, or gets worse week on week is not tolerance building slowly — that is the wrong product or too fast a ramp.
If azelaic acid is not tolerated
Niacinamide is the gentler option, working on barrier function rather than on inflammation directly. It is less powerful and considerably easier to live with, and for mild disease it is a reasonable place to settle rather than a consolation prize.
Ready for the next step?
Has the active been in use consistently for at least four weeks without escalating irritation?
Yes — it is established: That is the full over-the-counter plan running. Go to step 5 ↓ Go to step 4 ↓
No — it is still irritating: Drop back a frequency level and hold there for two more weeks. If it is still hostile at every-third-night, stop it and use the alternative above rather than pushing on.
- Weeks 4–12, alongside everything aboveYou are here
Find your own triggers
Identify the two or three things that actually set your face off, rather than adopting a published list wholesale.
What this step involves
Morning
- Keep a short daily note Date, how the skin looked, and anything notable — weather, alcohol, a hot drink, a hot room, exercise, a stressful day, a new product. Two lines is enough, and doing it daily matters far more than doing it thoroughly.
Evening
- Test one suspect at a time Once a pattern appears, remove that one thing for two weeks and see whether the flushing frequency drops. One suspect at a time, or the answer is unreadable — the same rule that governs adding products.
Why this step: Triggers in rosacea are genuinely individual. The published lists — sun, heat, alcohol, spicy food, exercise, stress, cold wind, hot drinks — describe what is common across populations, not what is true for any one person, and treating that list as a set of rules produces a life narrowed for no benefit. A fortnight of notes usually reveals that two or three items matter enormously and the rest matter not at all.
What's normal: Avoid the trap of avoiding everything. Exercise in particular is worth keeping — the cardiovascular benefit is not negotiable against a flush that lasts twenty minutes, and cooling strategies usually make it manageable.
If you only track one thing
Track heat, broadly defined — hot drinks, hot rooms, hot showers, saunas, sun on the face. It is the trigger most often missed because it is not a substance, and it is the one people most often find is doing the majority of the work.
Ready for the next step?
Have you identified at least one reliable personal trigger, or established that flushing seems unrelated to the usual suspects?
Yes — there is a pattern: That is worth taking to any appointment. Continue everything above until the 12-week checkpoint ↓ Go to the checkpoint ↓
Not yet: Keep the notes running — patterns often take six weeks to become visible. This does not hold up the checkpoint below.
The 12-week checkpoint
Twelve weeks counted from the start of step 2, when the barrier routine began — not from when the active was added.
How to judge it: Compare photographs rather than memory, taken in the same light at the same time of day, ideally daylight near a window rather than under a bathroom bulb. Rosacea changes slowly enough that daily observation reliably reports no change, and colour is the single thing artificial lighting distorts most.
Twelve weeks in, with the routine simplified and the active running as far as it was tolerated — what has actually changed?
Keep going, and change nothing yet.
Fewer bumps, less frequent flushing, skin that stings less. Rosacea relapses when treatment stops far more often than not, so the plan that produced this is the plan that maintains it. The temptation at this point is to start adding things back — the retinol, the vitamin C, the exfoliant. If you do, add one, wait a month, and be prepared to lose it again.
There is more available, and this is a reasonable point to ask for it.
Partial improvement means the approach is right and the strength is not. That is a good position to arrive at an appointment with, because it demonstrates the foundation is in place — a clinician can then add a prescription topical to something that is already working rather than starting over.
This is the handover point.
Twelve weeks of a simplified routine and a consistently used active, with nothing to show for it, is precisely the result this checkpoint exists to produce. It is not a sign that anything was done wrong. The prescription tier is meaningfully stronger than anything on this page, particularly for inflammatory bumps, and this is the evidence that justifies reaching for it.
Stop the active and simplify back to step 2.
Worse is not a weaker version of no-change and does not mean the next step up is stronger treatment. Skin that is more inflamed than it was twelve weeks ago is usually reacting to something in the routine, and the move is subtraction rather than escalation. Return to the cleanser and moisturiser alone, let it settle for a month, and take that history to a clinician — what a face reacts to is genuinely useful diagnostic information.
What does not wait for twelve weeks
Eye symptoms do not wait. Grittiness, burning or persistently red lid margins need looking at regardless of where the skin has got to, and pain, light sensitivity or any change in vision is a same-day matter rather than a checkpoint one. Nor does thickening wait: any coarsening or change in contour, particularly around the nose, is worth an appointment now rather than at week twelve, because the medical options for early phyma close as it becomes established. And a facial steroid cream that is being used to keep redness down should be raised with a clinician promptly rather than continued.
Photograph the same three views — straight on, and both sides — in the same light every two weeks. Rosacea moves slowly enough that memory is an unreliable witness, and colour is exactly what people misjudge over time. The photographs are also the single most useful thing to bring to an appointment, since a clinic visit on a calm day tells a dermatologist very little about what a flare actually looks like.
Where the over-the-counter pathway ends
The aisle ends at inflammation. Azelaic acid, a repaired barrier and daily photoprotection can reduce bumps considerably, soften background colour and make skin far less reactive — and none of them will remove a single visible vessel or reverse thickened skin. Those two features are structural, and structural change is answered with light, energy or surgery rather than with a cream. Reaching that boundary is not a failure of effort; it is the point at which the useful question changes from which product to which clinician.
See the prescription pathway below →Rosacea: the full therapy pathway · dermapproved.com/treatments/rosacea/ · not a diagnosis — confirm anything you act on with a clinician
What to expect
Rosacea is managed rather than cured, and being told that early is more useful than discovering it after three hopeful years. What treatment realistically delivers is a face that flushes less often, bumps that mostly stay away, skin that stops stinging at everything, and a condition that stops progressing — which is a substantially different life from where most people start, and is not the same as clear skin. The parts that respond fastest are the inflammatory ones: bumps and pustules often improve visibly within four to eight weeks of the right treatment. Background redness is slower and improves partially. Visible vessels do not respond to creams at all and need a procedure. Thickening does not reverse without one. Setting those four expectations separately is what stops people concluding a treatment failed when it simply was not aimed at the feature they were watching.
- Relapse on stopping treatment is the norm rather than a sign that something went wrong — maintenance is usually part of the plan
- The foundation routine is the part quietly abandoned once a prescription arrives, and it is the part that makes the prescription work
- Twelve weeks is a real trial length; four is not, and most abandoned treatments are abandoned in week three
- Photographs in consistent light beat memory, which systematically reports no change
- Reintroducing an old favourite product after improvement is how a good result gets undone — one at a time, a month apart
Worth going back to a clinician if new bumps break through a treatment that was working, if the eyes become involved at any point, if any thickening appears, if a treatment is producing rebound redness, or if what was prescribed is not tolerable. Rosacea changes over years, and a plan that fitted three years ago is not automatically the plan now.
What would bring you back sooner
Whatever step you are on, these do not wait for the end of a trial period. They are the same
presentations listed at the top of this page — repeated here because that is where they
matter, rather than where they were easiest to put.
- Any change in vision, eye pain, or light sensitivity Seek care quickly
- Sudden severe facial swelling with fever or feeling unwell Seek care quickly
- Flushing with diarrhoea, wheezing, palpitations or fainting See a dermatologist soon
- A red patch that is scaly, crusted, bleeds, or will not heal See a dermatologist soon
- Rosacea that flares fiercely every time a facial steroid cream is stopped Worth a clinician visit
Prescription only — from here on, this is a clinician's decision The prescription pathway
Why this tier exists. Here is the ceiling, stated plainly, because most of the internet declines to. Nothing available over the counter removes a visible blood vessel — no serum, no cream, no LED mask, no cold roller. Once a thread vein is there it is a structural change, and the only things that clear it are light and laser devices in a clinic. The same is true of established thickening: creams can stop it progressing, but they do not restore contour. Over-the-counter treatment can quiet the redness, reduce the bumps considerably, and make the skin far less reactive. It cannot make a dilated vessel disappear, and any product implying otherwise is selling optics.
Rosacea does not arrive as one thing, so it does not have one route. Read across the top for the feature that bothers you most — redness, bumps, thickening, eyes — and down the side for how far past the aisle each one goes. Most people have more than one column running at once, which is normal and is why the routes overlap.
The same pathway in full below — each step names what it involves, why it sits where it does, and what tells you it's time to move up. Tap any therapy to jump to its detail.
Redness, flushing and thread veins
Colour is the main complaint — flushing that has become frequent, a background red that no longer clears, or fine visible vessels across the cheeks and nose. This is the route where the over-the-counter tier does the least and the procedure tier does the most, which is the reverse of every other page on this site.
You reach this column when: The fixed redness is unchanged, or visible vessels are the thing that actually bothers you — because no topical, prescription or otherwise, will clear those.
- Prescription topical
Topical vasoconstrictors
Why this step sits here: These narrow the dilated vessels for a day at a time. They are genuinely effective at what they do and genuinely limited in what that is — an appearance treatment, not a disease treatment, with rebound as a real and reportable risk.
Two drugs, one idea. What separates them is not how well they work on the morning of application but how the day ends:
- Brimonidine 0.33% gel backed by large randomized trials
The longer-established of the pair, with colour visibly reduced inside an hour and an effect measured across most of a working day. It also carries the higher reported rate of rebound and of a paradoxical flush hours after application, which is why a first trial belongs on a quiet weekend.
- Oxymetazoline 1% cream backed by large randomized trials
A different receptor target, and in the pooled trial data worsening erythema was negligible. That profile suits someone who has already met rebound, or who wants this every day rather than before an occasion.
When to move up
- A fair trial
- A cautious trial on an unimportant day, repeated a few times to see how the skin behaves as the effect wears off.
- Improvement looks like
- Visibly less redness within an hour, holding for most of the day, with no worse-than-baseline flush as it fades.
- Move up if
- Rebound redness follows each use, the effect is too short to be worth it, or the thread veins remain the real complaint underneath.
→ The next step up this pathway.
-
- In-office procedure
Vascular laser and light
Why this step sits here: The only tier that removes a vessel rather than managing its behaviour. It sits at the top of this column not because it is drastic but because it is the answer to the part of rosacea that creams were never able to reach.
The device is chosen against what is actually visible, because a discrete vessel and a diffuse wash of colour do not answer to the same light:
- Pulsed dye laser backed by large randomized trials
The most-studied device for both thread veins and background colour, and the usual opening move. At the settings that clear vessels fastest it bruises for a week or two — a diary problem rather than a complication.
- KTP and other 532 nm lasers backed by smaller studies
Precise on individual visible vessels, which suits a face where a handful of specific lines are the complaint rather than an overall colour.
- Intense pulsed light backed by large randomized trials
Broader wavelengths over a wider area, which suits diffuse redness spread across the central face — and it is the device most often used when the eyelid margins are being treated in the same course.
Which device, at what settings, over how many sessions, and by whom — those are the questions here, and the last one predicts the result more reliably than the first. Deeper skin tones need a practitioner who treats them routinely, because the safe parameters differ and the cost of getting them wrong is a pigment change that outlasts the redness.
-
After the laser: keeping the gains
A cleared vessel does not come back, but the tendency that produced it has not been treated, so new ones form over the following years — which is why a course is usually followed by a top-up session every year or two rather than by nothing. What lengthens the gap between them is the unglamorous half: daily photoprotection, a routine that has stayed short, and triggers still being respected. The vasoconstrictors stay situational; using one every day to hold an appearance is how people find the rebound the trials describe.
Inflammatory bumps and pustules
Red bumps and pus-topped spots on a coloured background, without blackheads or whiteheads. This is the best-treated presentation of rosacea by a wide margin — the evidence is strongest here, the response is fastest, and most people who reach a clinician for it do well.
You reach this column when: New crops keep arriving after twelve weeks, the bumps are numerous or leaving marks, or nothing over the counter is tolerable enough to use consistently.
- Prescription topical
Prescription topicals
Why this step sits here: Topical ivermectin has the strongest comparative evidence in inflammatory rosacea, with metronidazole, prescription-strength azelaic acid, encapsulated benzoyl peroxide and minocycline foam as real alternatives chosen largely on tolerability and access.
Five topicals share this step, and in practice they are not put in an order. What decides is which one the skin tolerates, what is licensed and funded where you live, and whether pregnancy is in the picture:
- Ivermectin 1% cream backed by large randomized trials
The strongest performer in the comparative reviews, and the only one on this step that lowers mite density as well as inflammation. A sensible opening choice where bumps are numerous.
- Metronidazole 0.75–1% backed by large randomized trials
Decades of use, inexpensive nearly everywhere, and gentle. It suits skin that reacted badly to something stronger, and it is the agent with the clearest evidence for holding a remission once one is reached.
- Azelaic acid 15% backed by large randomized trials
The prescription strength of what is already on the shelf at 10%, and the member of this group generally regarded as compatible with pregnancy — which frequently settles the question on its own.
- Microencapsulated benzoyl peroxide 5% backed by large randomized trials
Benzoyl peroxide with its harshness engineered out by a slow-releasing silica shell, and the option that moved fastest in trials — separation from vehicle inside the first fortnight suits someone who has already waited a long time.
- Minocycline 1.5% foam backed by large randomized trials
A tetracycline applied rather than swallowed. It suits someone who needs antibiotic reach but has a reason to keep the exposure on the skin instead of through the body.
When to move up
- A fair trial
- Three to four months, because ivermectin in particular keeps improving well past the point most people assume it has finished.
- Improvement looks like
- A substantial drop in the number of inflammatory lesions and longer gaps between crops.
- Move up if
- Inflammation persists at three to four months, the disease is extensive, or flares keep breaking through the topical.
→ The next step up this pathway.
-
- Prescription oral
Oral anti-inflammatory dose antibiotics
Why this step sits here: Sub-antimicrobial doxycycline adds systemic anti-inflammatory control without meaningful antibiotic pressure, and is typically run alongside the topical rather than instead of it, with the topical continuing as maintenance once the course ends.
The oral step is a decision about dose before it is a decision about drug, and the modern default is the dose that is anti-inflammatory without being antibacterial:
- Sub-antimicrobial-dose doxycycline backed by large randomized trials
The usual first oral choice and the only oral drug licensed for rosacea in most markets. Head to head against a full antibiotic dose it matched on lesion counts while the stomach upset stayed in the other arm.
- Conventional-dose doxycycline or minocycline backed by smaller studies
Reached for where inflammation is heavy or the low dose has not held. This is a genuine antibiotic dose, so it comes with a defined end rather than an open-ended repeat prescription.
- Low-dose modified-release minocycline backed by large randomized trials
The newest arrival, whose phase 3 programme reported greater lesion reduction than both placebo and the established low-dose doxycycline comparator. Whether it is available where you are is currently the deciding factor.
- Sarecycline, macrolides and other alternatives limited evidence
Where a standard tetracycline is unsuitable — pregnancy, allergy, or a child whose adult teeth are not yet in — a prescriber has other options, on a thinner evidence base and usually for a shorter run.
When to move up
- A fair trial
- Two to three months of the tablets alongside a continuing topical.
- Improvement looks like
- Inflammation substantially controlled, with the topical able to hold it after the course finishes.
- Move up if
- Severe inflammatory disease persists on combined oral and topical treatment, or relapses hard every time the tablets stop.
→ The next step up this pathway.
-
- Prescription oral
Low-dose oral isotretinoin
Why this step sits here: Reserved for inflammatory rosacea that has resisted the standard ladder. Used at doses well below acne dosing, with specialist supervision, blood monitoring and — for anyone who can become pregnant — a formal pregnancy-prevention programme.
Whether this step is proportionate depends on how much of your life the condition is taking up, not on a lesion count. The relevant questions are what dose, for how long, what monitoring is involved, what happens when it stops — relapse is more common here than in acne — and, for anyone who can become pregnant, exactly what the prevention programme requires before the first tablet.
When the bumps stop, one thing continues
This is the route where stopping everything is the classic mistake. The oral course ends by design; the topical is what stays, and it has been tested exactly that way — people already cleared and then randomised to continue a topical or its vehicle relapsed far less on the drug over the following six months. In practice maintenance often means the same cream at a lower frequency, and needing it is not a sign the treatment underperformed. Rosacea is a condition that is held rather than finished.
Thickening and phyma
The skin itself is changing texture and contour — coarsening, enlarged pore openings, and firmness that does not settle when the redness does. Most commonly the nose, sometimes the chin, forehead or ears. Timing matters more in this column than any other: early thickening has medical options, established phyma does not.
You reach this column when: Any thickening or coarsening of texture is present at all, whether or not it is progressing.
- Prescription oral
Low-dose oral isotretinoin
Why this step sits here: The main medical option for early phymatous change, aimed at the sebaceous overgrowth before fibrous tissue is laid down. Once the change is structural, drugs stop being the answer — which is why the referral is worth making early.
When to move up
- A fair trial
- A supervised course over several months, with the effect on contour assessed against photographs rather than memory.
- Improvement looks like
- Softening of early thickening, reduced sebaceous prominence, and inflammation controlled.
- Move up if
- The contour change is established, fibrous and unaffected by medical treatment.
→ The next step up this pathway.
- In-office procedure
Reshaping
Why this step sits here: Ablative laser, electrosurgery or surgical debulking to restore contour, followed by continued medical treatment so the process that produced it stays controlled.
Reshaping is one goal reached with several instruments, and the choice turns on how much tissue there is and what the surgeon does most:
- Ablative CO2 or erbium laser backed by smaller studies
The common modern approach to moderate thickening, taking tissue away in controlled layers and leaving a surface that heals over the restored contour.
- Electrosurgical sculpting and dermabrasion backed by smaller studies
Long-established techniques, frequently combined with laser in the same sitting, and still what many surgeons find most controllable on a bulky nose.
- Surgical debulking limited evidence
For substantial phyma where volume has to come off before any surface work makes sense — sometimes staged across more than one operation, and reported to restore function as much as appearance.
This is a surgical conversation with a real recovery period, and the questions worth asking are about the operator's experience with phyma specifically, what the healing fortnight actually involves, and what medical treatment continues afterwards. Reshaping without treating the underlying disease invites a repeat.
-
Protecting a reshaped contour
Reshaping treats tissue, not disease — the process that built the phyma is still running the day after surgery, and recurrence over years is the documented cost of leaving it alone. So the medical treatment continues afterwards, aimed at the inflammation rather than the shape, and the surface that has just healed needs shielding from ultraviolet more carefully than the skin around it. Photographs at intervals are worth more than impressions here, because contour change is slow enough to be invisible month to month and obvious across two years.
Eye involvement
Gritty, burning, dry or bloodshot eyes, crusted or inflamed lid margins, recurrent styes. It affects a large share of people with rosacea, often arrives before anything visible on the skin, and is regularly attributed to screens or allergies for years before anyone connects it to the face.
You reach this column when: Symptoms persist beyond six weeks, styes keep recurring, or there is any pain, light sensitivity or change in vision — the last of which does not wait at all.
- Specialist care
Ophthalmology assessment and therapy
Why this step sits here: An eye examination establishes whether the cornea is involved, which is the fact that determines urgency and treatment. Oral tetracyclines are frequently the systemic treatment used, prescribed and monitored with the eye findings in view.
Eye treatment runs on its own track, and the systematic review of it found most approaches producing a response in the great majority of patients — so the choice is about fit and about who is prescribing, not about which one works:
- Lid hygiene, warm compresses and preservative-free tears backed by smaller studies
The floor under everything else, and the review put roughly two thirds of patients on lid care alone at a partial or complete response. It fails on consistency far more often than on effect.
- Ciclosporin 0.05% ophthalmic emulsion backed by large randomized trials
Prescribed by an eye clinician where the tear film is the problem; in a head-to-head trial it moved symptoms and tear measurements further than an oral antibiotic did, without anything being swallowed.
- Oral tetracyclines backed by large randomized trials
The systemic option with the longest record here, including the same low dose used for the skin — which suits someone whose face and eyes are both inflamed and who would rather treat them once.
- Topical azithromycin or ivermectin at the lid margin backed by smaller studies
Applied where the problem is rather than taken by mouth, which suits someone who would prefer not to be on a systemic antibiotic for months.
- Lotilaner 0.25% ophthalmic solution backed by large randomized trials
Licensed specifically against Demodex blepharitis, which overlaps heavily with ocular rosacea. It fits where mites have actually been seen on the lashes rather than assumed from the symptoms.
The question to ask at this appointment is whether the cornea is affected, because that single answer separates a chronic irritation managed with compresses and drops from a condition needing close ophthalmic follow-up. It is also worth mentioning the skin diagnosis explicitly — the connection is missed often enough that it is worth naming rather than assuming.
-
Lid care is the long game, not the opening move
Every other route on this page has a maintenance phase that is quieter than the treatment phase. This one does not: the compresses and lid cleaning that settled the symptoms are also the thing that keeps them settled, and grittiness returns within weeks of the routine lapsing. Where the cornea has ever been involved, a periodic eye check continues regardless of how comfortable things feel, because the eye's warning signs and its actual state are not as tightly coupled as anyone would like.
Rosacea: the full therapy pathway · dermapproved.com/treatments/rosacea/ · not a diagnosis — confirm anything you act on with a clinician
When the rules change
The four routes above assume an adult face, no pregnancy, and rosacea that arrived slowly. Here is what changes when one of those does not hold — and in three of the four, what changes is that the answer is a clinician sooner rather than a product first.
Pregnant, breastfeeding, or planning to be
Rosacea behaves unpredictably in pregnancy — settling for some people and flaring hard for others — and the ladder narrows at exactly the point it may be most needed. That reads as 'nothing until afterwards' and it is not: what happens is that the starting point moves down a rung and the foundation carries more weight.
What can be used
- Azelaic acid, over the counter at 10% or on prescription at 15% — the active that most often survives this filter intact
- The whole foundation: gentle cleansing, barrier repair, and a mineral sunscreen every morning
- Topical metronidazole, which is frequently continued where a prescriber judges the benefit worth it
- Warm compresses, lid cleaning and preservative-free tears for eye symptoms, unchanged by pregnancy
- Where systemic treatment is genuinely needed, a macrolide such as erythromycin is what obstetric and dermatology teams usually consider together
What comes off the table
- Oral tetracyclines, which affect a developing baby's teeth and bones
- Oral isotretinoin, which causes severe birth defects and is governed by a formal pregnancy-prevention programme
- Topical retinoids, withdrawn for the same class reason
- Elective laser and reshaping — not because harm is established, but because there is nothing to gain by accepting an unknown for a benefit that will still be there in a year
Each of these is a conversation with whoever is providing antenatal care rather than a decision to make alone. It is also worth revisiting: a plan that fitted in the first trimester regularly needs rewriting by the third.
Rosacea before adulthood
Uncommon, real, and routinely missed — partly because nobody is looking for it in a nine-year-old, and partly because the eyes often go first. Recurrent styes and chalazia in a child with a family history of rosacea is the picture that gets attributed to hygiene for a year or two, and corneal involvement is reported often enough in paediatric series that the eye assessment is not the optional part.
What can be used
- The same foundation routine, in its simplest form
- Topical metronidazole or azelaic acid, which is where treatment usually starts
- Daily lid hygiene, which carries even more of the load here than in adults
- A macrolide such as erythromycin where systemic treatment is needed before adult teeth are established
What comes off the table
- Tetracyclines below roughly age eight, for the same reason they are avoided in pregnancy
- Topical steroids on a child's face, which reliably calm it and then reliably make it worse
Paediatric rosacea is generally managed by a dermatologist and an eye clinician between them, and the family history is worth mentioning at both appointments — it is often the detail that makes the diagnosis land.
When it arrives all at once: rosacea fulminans
Coalescing pustules, nodules and abscesses erupting across the central face over days to weeks, most often in women between their twenties and forties, usually on a background of rosacea or flushing and often around a hormonal shift such as pregnancy. It is rare, it looks frightening, and it is the one presentation on this page where waiting to see if it settles is the wrong instinct — scarring is what the delay costs. In the largest review of reported cases, symptoms ran under three months in most people and recurrence was uncommon, which is a genuinely reassuring picture once treatment has started.
What can be used
- Prompt dermatology assessment, which is the step that changes the outcome here
- An oral corticosteroid to settle the acute inflammation, tapered as it comes down
- Oral isotretinoin added alongside it, typically continued for a few months
- An oral antibiotic instead, where isotretinoin cannot be used — including in pregnancy, where corticosteroid with a macrolide has been used and reported
What comes off the table
- Treating it as an ordinary flare and persevering with a topical, which does not reach inflammation at this depth
- Anything abrasive or drying on skin that is already breaking down
Almost everything known about this comes from case series rather than trials, so descriptions of treatment are descriptions of what has been done rather than of what has been proven. It appears here because it is regularly mistaken for a sudden acne flare, and the two are handled very differently.
Two variants the main routes do not describe
Both of the following are uncommon, both are refractory to most of what is above, and both are named here for the same reason: someone who has one of them will otherwise conclude that treatment failed them personally, when what actually happened is that they were on the wrong page of the map.
- Persistent facial swelling (Morbihan disease)
- Firm, non-pitting swelling of the eyelids, cheeks, forehead or nose that stays put when the redness settles, and which can eventually narrow the field of vision. There is no consistently successful protocol, but the systematic review of reported cases found response tracking with how long treatment ran rather than which drug was chosen — responders averaged months of a tetracycline, and those who cleared completely averaged longer still. Surgery to the eyelids is used where the swelling is obstructing sight.
- Neurogenic rosacea
- Burning, stinging and flushing far out of proportion to what is visible, often with the pain outlasting the colour, and characteristically unresponsive to the topical and oral treatments that handle ordinary rosacea. What has been reported to help is borrowed from neurology and pain medicine rather than dermatology, which makes this a referral rather than a routine to try harder at.
Neither is common enough to have a guideline behind it, and the literature on both is case reports and small series. That is a reason to be seen by someone who has met the variant before, not a reason to assume nothing can be done.
How an appointment actually happens, what to take to it, and how to keep your skin liveable while a prescription or procedure does its work.
What seeing a dermatologist actually looks like
Rosacea is diagnosed clinically — by examination and history, without a test — which means an appointment is largely about what a clinician can see and what you can describe. That makes the timing awkward, because rosacea has the courtesy to look its best in waiting rooms. Photographs taken during a flare, in daylight, are consequently the most valuable thing to arrive with. In many systems a first appointment is with a family doctor or GP, who can prescribe most of the topical and oral treatments on this page; dermatology referral tends to be for diagnostic uncertainty, disease resistant to first-line treatment, phymatous change, or when isotretinoin is being considered. Laser and light treatment is usually a separate referral again and is frequently not publicly funded.
What to bring
- Photographs from a flare day, taken in daylight — the single most useful item
- A trigger diary, even a rough one, covering a few weeks
- A list of every product currently used on the face, including cleansers and makeup
- What has already been tried, at what strength, for how long, and what happened
- Any facial steroid cream used recently, which matters more than people expect
- A note of eye symptoms, even mild ones, since they are easy to forget in a skin appointment
Questions worth asking
- Which features do I actually have — is this inflammatory, vascular, or both?
- Is there any thickening starting, and if so does that change the urgency?
- Should my eyes be checked, and by whom?
- What is this treatment aimed at — the bumps, the colour, or the vessels?
- How long before we judge whether it is working, and what does working look like?
- What happens when I stop, and is there a maintenance plan?
- Is anything here affected by pregnancy, now or later?
Cost and access. The topical and oral treatments on this page are widely prescribable and often inexpensive, particularly the older ones — metronidazole and generic doxycycline cost little in most systems. Newer branded topicals can be considerably more expensive and are not always reimbursed. Laser and light treatment is the significant cost: it is usually classed as cosmetic, is typically paid for privately, and a course of several sessions adds up. That classification is worth challenging where vessels are extensive, since some systems distinguish between cosmetic and functional treatment.
A family doctor or GP can diagnose rosacea and prescribe the majority of what appears on this page. Asking for a dermatology referral is reasonable when the diagnosis is uncertain, when first-line treatment has not worked, when thickening is present, or when isotretinoin is on the table — and asking for an eye referral is reasonable whenever ocular symptoms are present, regardless of how the skin looks.
Finding someone to see
How you reach a clinician differs by country, and in several systems the first appointment is deliberately with a family doctor rather than a specialist.
- US Find a Dermatologist American Academy of Dermatology Searchable by location and condition; the directory verifies board certification.
- Canada Find a Dermatologist Canadian Dermatology Association Certified dermatologists by city or postal code. A family doctor's referral is usually required first.
- UK Rosacea — NHS overview NHS Sets out when to see a GP and what NHS treatment covers. Laser treatment is rarely funded.
- Australia Rosacea — healthdirect healthdirect Australia Government-funded health information, including when to see a doctor and how referral works.
Regions are listed only where a directory or national health service page could be verified directly. Absence here means we could not confirm a source, not that care is unavailable.
Skincare alongside therapy
What goes on the skin around a rosacea treatment decides whether the treatment is tolerable. This is not comfort advice appended to the real plan — on a barrier this permeable, supporting care is load-bearing.
Everything here is chosen for what it does not do. A supporting product's job in rosacea is to be unnoticeable: no fragrance, no acids, no scrub, no heat, no sting. The best cleanser for a rosacea face is the one you would struggle to describe afterwards.
The everyday routine, whatever else is running
This is the routine that stays constant underneath every rung of every route above — through prescriptions, through a laser course, through pregnancy. It is three products, and its virtue is that it is boring.
Do
- Wash with lukewarm water and a non-foaming cleanser, using fingertips rather than a cloth or brush
- Apply moisturiser to slightly damp skin, which improves how much water it retains
- Use a mineral sunscreen every morning, including in winter and indoors near windows
- Pat dry rather than rubbing — a towel is more abrasive on reactive skin than most people credit
- Introduce anything new one item at a time, with a fortnight between introductions
Avoid
- Foaming or stripping washes, and anything that leaves the skin feeling tight
- Scrubs, brushes, sponges and any mechanical exfoliation at all
- Fragrance and essential oils, including those marketed as calming — lavender, peppermint, menthol, camphor and citrus oils in particular
- Alcohol-heavy toners and astringents
- Very hot water on the face, including in the shower
What that looks like on a shelf: a gentle cleanser, a barrier moisturizer, a mineral sunscreen.
While an active or prescription topical is running
The first fortnight of any rosacea topical is the fortnight people quit in. Most of what makes that survivable is scheduling and buffering rather than the product itself.
Do
- Buffer by applying moisturiser before the active on days the skin feels reactive
- Build frequency in steps — every third night, then alternate, then daily — rather than starting at the label's maximum
- Expect a warm prickle for the first two to three weeks and judge it by whether it is decreasing
- Keep the moisturiser going on top; it does not cancel the active out
- Photograph every fortnight in consistent light, since week-to-week change is invisible in a mirror
Avoid
- Adding a second active at the same time, which makes any reaction unattributable
- Applying to skin that is still stinging from cleansing
- Treating escalating burn as tolerance building — that direction of travel means stop
- Stopping and restarting repeatedly, which is the pattern that produces twelve weeks of no result
What that looks like on a shelf: a barrier moisturizer, a gentle cleanser.
Around a laser or reshaping procedure
Aftercare here is genuinely medical and is directed by the clinic that performed the procedure. What follows supports that rather than replacing it — and where the two disagree, the clinic wins.
Do
- Follow the clinic's aftercare instructions in preference to anything written here
- Keep the area scrupulously protected from sun while it heals, which is when pigment change is most likely
- Use a bland emollient and nothing else on treated skin until told otherwise
- Expect bruising after pulsed dye laser and plan the calendar around it rather than being surprised
Avoid
- Restarting actives before the clinic says so
- Picking or exfoliating healing skin, which is how a temporary mark becomes a permanent one
- Heat exposure — saunas, hot yoga, long hot showers — while healing
What that looks like on a shelf: an emollient for everywhere, a mineral sunscreen.
Alongside eye involvement
Lid care is unglamorous, takes five minutes, and is abandoned by most people within a month. Done consistently it is the single most effective thing available for ocular rosacea outside a clinic.
Do
- Warm compress on closed lids for several minutes daily, long enough that the heat actually reaches the glands
- Clean the lid margins gently afterwards with a product intended for eyelids
- Use preservative-free artificial tears if the eyes are dry, since preservatives with frequent use can irritate further
- Mention the rosacea diagnosis at any eye appointment — the link is missed regularly
Avoid
- Over-the-counter redness-relief eye drops, which constrict vessels and can rebound in the eye much as they do on the face
- Rubbing, which inflames lid margins that are already inflamed
- Assuming that calm skin means calm eyes — the two do not track each other
What that looks like on a shelf: a gentle cleanser.
The supporting shelf
A gentle cleanser
A barrier moisturizer
A mineral sunscreen
An emollient for everywhere
Product roles above link to whatever currently grades best for that job in our catalog, filtered for fragrance-free formulation and low irritation potential. They are suggestions of a category rather than of a specific bottle — the category is the part that matters.
Every therapy named above, in full. Look things up here; it is not meant to be read end to end.
Every therapy, explained
Reference, not reading — every therapy named anywhere above, described the way a clinician would describe it. Nobody reads this section end to end; open the one you were sent here for. Which one is right for you is the appointment's job, not this page's.
Over the counter
Available without a prescription. Each one opens with what to look for on a label, which is the part that stays true regardless of which brand is on the shelf that month.
Over-the-counter Stopping what is provoking it
Trigger and routine reduction
Generally compatible
Stopping what is provoking it
Trigger and routine reduction
The first treatment, and the only one that costs nothing. Rosacea skin is more permeable and more reactive than normal skin, so a routine that would be unremarkable on anyone else becomes a daily provocation here.
At the shelf
Nothing. This is the one entry on this page with no product attached.
The action is removal: the foaming or stripping wash, the scrub, the acid toner, the alcohol-heavy tonic, the fragranced cream, the sting-and-persevere vitamin C, and the hot water. A rosacea routine that works is usually three products long, and getting there is the single highest-yield move available without a prescription.
Watch out for: Anything promising to 'repair the capillaries', LED masks marketed for redness on the strength of testimonials, and cryo-rollers. Cooling feels wonderful on a flushing face and does nothing to the underlying vessel.
How it works
Removing surfactant stripping, mechanical abrasion and repeated low-grade irritation lets the barrier recover, which reduces how much of everything else penetrates and how readily the vessels respond. It also removes the confounder: it is impossible to judge whether a treatment is working while something else is still setting the skin off.
What the evidence says well established
Gentle skin care and trigger avoidance are recommended as foundational in current international management guidance rather than as adjuncts, and lifestyle and environmental trigger identification — classically via a diary — is specifically advised.
Typical course
Two to four weeks of a deliberately boring routine before adding anything back. Most people see the reactivity settle within that window even though the redness itself takes longer.
Commonly discussed side effects
- The skin can feel worse for the first week or so as it stops being exfoliated
- It is psychologically difficult to treat a visible problem by doing less
Worth knowing
- Triggers are individual — the published lists are a starting point, not a prescription, and a diary beats a list
- Avoiding every reported trigger would leave a person unable to exercise, drink anything warm, or go outside. That is not the goal and is a recognised harm of the trigger-avoidance framing
Pregnancy: Simplifying a routine carries no pregnancy considerations at all, and during pregnancy it matters more than usual: several of the actives above this rung are withdrawn, so the gentler foundation is carrying more of the load.
Why it sits where it does: It sits before every other rung because it changes what those rungs are working against. A prescription applied to skin that is being stripped twice a day is being asked to out-treat an ongoing injury, and that is the commonest reason a reasonable plan quietly fails.
Over-the-counter Azelaic acid 10%
Over-the-counter anti-inflammatory acid
Generally compatible
Azelaic acid 10%
Over-the-counter anti-inflammatory acid
The most useful thing you can buy for rosacea without a prescription, and unusually for this site, the over-the-counter and prescription versions differ only by strength.
At the shelf
Azelaic acid at 10%, in a gel or cream rather than a wash — contact time is the point.
The prescription version is the same molecule at 15%, so the over-the-counter product is a genuine lower dose of a real drug rather than a cosmetic imitation of one. Suspension-style formulas are thicker and can pill under sunscreen; gel and cream bases behave better under a mineral SPF.
Watch out for: Blends that bury a token amount of azelaic acid inside a long botanical list without stating a percentage. If the number is not on the box, it is decorative.
Browse all azelaic acid products in our catalog →
How it works
It dampens the inflammatory arm of rosacea directly — reducing the production of the reactive oxygen species released by neutrophils and interfering with the abnormal cathelicidin processing that drives the condition. That is a mechanism aimed at what rosacea actually is, rather than at redness as a symptom.
What the evidence says well established
Azelaic acid is among the topical treatments with the most consistent supporting evidence for papulopustular rosacea, and it appears as a recommended option across current guidance and systematic reviews.
Typical course
Once daily to start, twice if comfortable, judged at 12 weeks. Improvement in bumps often shows by week four; the background colour lags well behind it.
Commonly discussed side effects
- Stinging and a warm prickle for the first fortnight, which usually settles
- Mild dryness or flaking early on
- A transient itch on application
Worth knowing
- The initial sting is expected and fades; a sting that worsens over weeks is not tolerance failing, it is the wrong product
- Applied to a stripped barrier it will be intolerable — which is why it belongs after the subtraction step, not before it
Pregnancy: Azelaic acid is generally regarded as compatible with pregnancy and is frequently the active people are steered toward when tetracyclines and retinoids come off the table. Worth confirming with whoever is providing antenatal care.
Why it sits where it does: It leads the over-the-counter actives because it treats the inflammatory mechanism rather than the appearance, and because it is the one active on this rung that keeps its place in the plan during pregnancy.
Over-the-counter Barrier repair and niacinamide
Barrier restoration
Generally compatible
Barrier repair and niacinamide
Barrier restoration
The unglamorous half of rosacea treatment and the half that decides whether the other half is tolerable.
At the shelf
A fragrance-free moisturiser with ceramides, glycerin or niacinamide, in the simplest formula available.
Short ingredient lists genuinely matter here in a way they do not for most skin. Rosacea skin is more permeable, so every additional fragrance, essential oil or botanical extract is another candidate for the thing that stings. Niacinamide around 4–5% is the usual useful range and appears in plenty of ordinary moisturisers.
Watch out for: 'Calming' botanical complexes built on lavender, peppermint, witch hazel or citrus oils. Those are among the more reliable stingers on reactive facial skin, whatever the packaging says about soothing.
Browse all ceramides products in our catalog →
How it works
Rosacea skin loses water through the barrier faster than normal skin and lets more of what is applied pass through it. Replacing the missing lipids and supporting the skin's own production reduces both — which lowers baseline reactivity and, in practice, is what allows an active like azelaic acid to be used at all.
What the evidence says strong
Barrier impairment is a well-described feature of rosacea skin, and emollient use with gentle cleansing is recommended as a core component of management across current guidance rather than as optional comfort.
Typical course
Twice daily, indefinitely, including through every treatment above this rung and after them.
Commonly discussed side effects
- Heavier formulas can feel occlusive on skin that already runs warm
Worth knowing
- Patch test on the inner forearm or beside the ear for several days before putting anything new on a reactive face
- 'Fragrance-free' and 'unscented' are not the same claim — the second can mean a masking fragrance was added
Pregnancy: Emollients, ceramides and topical niacinamide are considered compatible with pregnancy and breastfeeding, and this rung is often the one doing the most work when the rest of the ladder is unavailable.
Why it sits where it does: It sits alongside the actives rather than beneath them because it is what makes them survivable. Rosacea is the condition where the moisturiser is not the thing you do after treatment — it is part of the treatment.
Over-the-counter Daily mineral photoprotection
Photoprotection
Generally compatible
Daily mineral photoprotection
Photoprotection
The best-supported preventive measure in rosacea, and the one most often treated as optional because its benefit is invisible.
At the shelf
Broad-spectrum SPF 30 or higher built on zinc oxide or titanium dioxide, fragrance-free, in a formula you will actually tolerate daily.
Mineral filters are the usual first choice in rosacea for two reasons: they sit on the surface rather than absorbing light and releasing it as heat within the skin, and they tend to sting less on a compromised barrier. Silicone-containing bases often feel more comfortable here than alcohol-containing fluid ones. A green-tinted formula also neutralises the appearance of redness, which is cosmetic rather than therapeutic but is not nothing.
Watch out for: Very high SPF numbers bought for their own sake. The gap between SPF 30 and SPF 50 is small compared with the gap between a sunscreen worn daily and one that stings so much it lives in a drawer.
Browse all zinc oxide products in our catalog →
How it works
Ultraviolet exposure induces the inflammatory cascade rosacea is built on and drives the vascular changes underneath it over years. Blocking it does not calm today's flush; it reduces how much worse the condition gets and how often it is provoked.
What the evidence says well established
Sun exposure is the most consistently reported trigger in rosacea patient surveys, and daily broad-spectrum photoprotection is recommended as a standard component of management in current guidance.
Typical course
Every morning, all year, reapplied on days spent outdoors. This is the rung that never stops.
Commonly discussed side effects
- Mineral filters can leave a cast on deeper skin tones, which tinted formulations largely solve
- Some formulas pill over an azelaic acid layer — a minute between products usually fixes it
Worth knowing
- Heat is an independent trigger from ultraviolet light, so sunscreen does not make a hot day safe
- Chemical filters are not forbidden and suit some people better — tolerability beats filter class
Pregnancy: Sunscreen is compatible with pregnancy, and mineral filters are the option people most often choose when they would rather minimise absorbed ingredients.
Why it sits where it does: It sits on the foundation rung with subtraction and barrier care because it is preventive rather than corrective. Nothing about it clears today's redness, and it is among the few interventions that changes the trajectory.
Browse the whole catalog for this condition:
What changed recently: The most useful development over the counter has not been a new molecule but a change in framing: gentle, barrier-first skincare moved from being advice a dermatologist gave at the end of an appointment to being a formal part of international management recommendations. That sounds like a small thing and is not — it is the difference between 'moisturise if you like' and 'the emollient is part of the treatment'. Alongside it, azelaic acid became far easier to buy at 10% without a prescription in most markets.
Prescriptions and procedures
About the brand names below. Brand names are what the pharmacy label says; the generic name underneath is what actually matters, and it is the part that stays true when a brand is discontinued or a region carries a different one. Where a region is missing from a card below, that reflects what could be verified rather than proof of absence.
Prescription labels below link to national medicines sources rather than to manufacturers. A label describes the licensed use in that country, which is not always the use described here — several rosacea treatments are prescribed off-label, which is routine and lawful and simply means the leaflet will not mention your skin.
Prescription topical Topical ivermectin 1%
Antiparasitic and anti-inflammatory topical
Individualized — ask a clinician
Topical ivermectin 1%
Antiparasitic and anti-inflammatory topical
The prescription topical with the strongest performance in inflammatory rosacea, and the one that made the mite argument respectable.
What it's called at the pharmacy
Generic name Topical ivermectin 1%
Sold as
- Soolantra — ivermectin 1% cream, FDA-approved in 2014 for the inflammatory lesions of rosacea
- Soolantra — authorised for inflammatory lesions of papulopustular rosacea in adults
Where a region is absent below, that reflects what could be verified rather than proof the product is unavailable there.
How it works
Two actions at once, which is why it outperforms older options: it kills Demodex mites, whose density is markedly elevated on rosacea skin and whose death releases material the immune system reacts to, and it is independently anti-inflammatory. Whether the mite is a cause or a passenger is still argued; the treatment works either way.
What the evidence says well established
Topical ivermectin has among the strongest evidence of any topical for papulopustular rosacea in systematic reviews using GRADE assessment, and has generally outperformed topical metronidazole in head-to-head comparison.
Typical course
Once daily, with the effect building over three to four months. Remission after a course tends to last longer than with older topicals.
Commonly discussed side effects
- Burning or stinging on application
- Dryness
- A transient worsening in the first weeks, thought to relate to the mite die-off
Worth knowing
- The early flare is well recognised and is not a reason to stop, but it is worth being told about beforehand rather than discovering it
- It treats bumps, not background redness — expectations set on the wrong feature read as failure
Pregnancy: Topical ivermectin has limited human pregnancy data and systemic absorption is low. Whether to continue is a decision for the prescriber alongside antenatal care rather than a general rule.
Why it sits where it does: It sits on the first prescription rung because it is the most effective topical for inflammatory lesions in the comparative evidence, and because its second mechanism reaches something the over-the-counter tier cannot touch at all.
Prescription topical Other prescription topicals
Metronidazole, azelaic acid 15%, encapsulated benzoyl peroxide, minocycline foam
Individualized — ask a clinician
Other prescription topicals
Metronidazole, azelaic acid 15%, encapsulated benzoyl peroxide, minocycline foam
The rest of the prescription topical shelf. Several are genuine alternatives rather than second choices, and which one is chosen often turns on tolerability rather than potency.
- Metronidazole 0.75–1% — The long-standing first-line topical; well tolerated, cheap, and still widely prescribed.
- Azelaic acid 15% — The prescription strength of the active available at 10% over the counter.
- Encapsulated benzoyl peroxide 5% — Benzoyl peroxide made tolerable for rosacea skin by holding it in a silica shell that releases it slowly — ordinary benzoyl peroxide is usually far too harsh here.
- Minocycline 1.5% foam — A topical tetracycline, delivering the antibiotic to the skin without the systemic exposure.
What it's called at the pharmacy
Generic names Metronidazole 0.75–1% · Azelaic acid 15% · Encapsulated benzoyl peroxide 5% · Minocycline 1.5% foam
Sold as
- Finacea — azelaic acid 15% gel and foam
- Epsolay — microencapsulated benzoyl peroxide 5% cream
- Zilxi — minocycline 1.5% topical foam
- Metronidazole is dispensed generically and under several brand names
- Rozex — metronidazole 0.75% cream and gel
- Finacea — azelaic acid 15% gel
Where a region is absent below, that reflects what could be verified rather than proof the product is unavailable there.
How it works
Different routes to the same destination: metronidazole is anti-inflammatory and reduces reactive oxygen species, azelaic acid interferes with cathelicidin processing, encapsulated benzoyl peroxide is antimicrobial and anti-Demodex with its harshness engineered out, and topical minocycline delivers a tetracycline locally.
What the evidence says strong
Topical metronidazole and azelaic acid are long-established options with consistent trial support for papulopustular rosacea; encapsulated benzoyl peroxide and minocycline foam are more recent additions with supporting randomised evidence.
Typical course
Once or twice daily depending on the agent, assessed over three months, often continued at a reduced frequency as maintenance.
Commonly discussed side effects
- Local irritation, stinging and dryness across the class
- Encapsulated benzoyl peroxide can still bleach fabric despite the encapsulation
Worth knowing
- Ordinary over-the-counter benzoyl peroxide is not a substitute for the encapsulated formulation — the shell is the entire reason it is tolerable on rosacea skin
- Rosacea relapses on stopping topical treatment more often than not, so maintenance is usually part of the plan rather than a sign of failure
Pregnancy: Azelaic acid is the member of this group generally regarded as compatible with pregnancy. Topical metronidazole is often continued where the benefit justifies it, and the newer agents have limited data — each is a prescriber conversation rather than a blanket answer.
Why it sits where it does: It shares the first prescription rung with ivermectin rather than sitting below it, because for many people the deciding factor is which one their skin tolerates and what is funded where they live.
Prescription topical Topical vasoconstrictors
Alpha-adrenergic agonists for persistent erythema
Individualized — ask a clinician
Topical vasoconstrictors
Alpha-adrenergic agonists for persistent erythema
The only prescriptions aimed squarely at fixed redness rather than at bumps — and the two drugs on this page whose limitations most need stating before use rather than after.
- Brimonidine 0.33% gel — Once daily; effect begins within half an hour and lasts up to twelve.
- Oxymetazoline 1% cream — Once daily; a different receptor profile, and in practice reported to rebound less often.
What it's called at the pharmacy
Generic names Brimonidine 0.33% gel · Oxymetazoline 1% cream
Sold as
- Mirvaso — brimonidine 0.33% topical gel
- Rhofade — oxymetazoline 1% cream
- Mirvaso — brimonidine 3 mg/g gel
Where a region is absent below, that reflects what could be verified rather than proof the product is unavailable there.
How it works
They constrict the dilated facial blood vessels directly by acting on alpha-adrenergic receptors in the vessel walls. That is a cosmetic mechanism in the literal sense — it changes how the skin looks for a day and treats nothing underneath.
What the evidence says strong
Both agents have randomised evidence for reducing persistent facial erythema, with a clear onset and a duration measured in hours. Rebound erythema — redness returning worse than baseline as the effect wears off — is a recognised effect, reported more commonly with brimonidine.
Typical course
Once daily or before an occasion. Many people use them situationally rather than every day, which is a legitimate way to use them.
Commonly discussed side effects
- Rebound redness worse than the starting point, sometimes within hours
- A paradoxical flush
- Burning and stinging
- Rarely, a blanched appearance that looks unnatural
Worth knowing
- Trying it for the first time on the morning of an important event is how people discover rebound at the worst possible moment. A quiet weekend is the sensible trial
- These do nothing for bumps and nothing for thread veins; used as a general rosacea treatment they will disappoint
- Applying more than prescribed increases rebound rather than effect
Pregnancy: Human pregnancy data for both agents are limited. Given the benefit is cosmetic and temporary, deferring during pregnancy is a straightforward decision for many people, and is worth raising rather than assuming.
Why it sits where it does: It sits on the prescription topical rung but off to one side, because it is the only entry here that targets appearance rather than disease. Nothing about it changes the course of rosacea, and used with that understanding it is genuinely useful.
Prescription oral Oral tetracyclines
Anti-inflammatory dose doxycycline and related
Avoid in pregnancy
Oral tetracyclines
Anti-inflammatory dose doxycycline and related
The step up from creams for inflammatory rosacea, and the drug class where the interesting fact is the dose rather than the molecule.
- Doxycycline 40 mg modified release — A sub-antimicrobial dose licensed specifically for rosacea — anti-inflammatory without meaningful antibiotic pressure.
- Doxycycline 50–100 mg — Conventional antibiotic dosing, used where inflammation is severe.
- Minocycline — An alternative tetracycline, including a modified-release oral formulation.
What it's called at the pharmacy
Generic names Doxycycline 40 mg modified release · Doxycycline 50–100 mg · Minocycline
Sold as
- Oracea — doxycycline 40 mg modified-release capsules, licensed for the inflammatory lesions of rosacea
- Efracea — doxycycline 40 mg modified-release capsules
Where a region is absent below, that reflects what could be verified rather than proof the product is unavailable there.
How it works
At 40 mg modified release, doxycycline sits below the concentration that suppresses bacteria and retains its separate anti-inflammatory activity — inhibiting the matrix metalloproteinases and the cathelicidin processing that drive rosacea. It works as an anti-inflammatory drug that happens to be an antibiotic, which is why resistance is not the concern it would otherwise be.
What the evidence says well established
Sub-antimicrobial-dose doxycycline has randomised evidence in papulopustular rosacea and is a recommended systemic option in current guidance, with comparable efficacy to higher antibiotic doses and fewer gastrointestinal effects.
Typical course
A course of several months, usually alongside a topical, with the topical continuing as maintenance after the tablets stop.
Commonly discussed side effects
- Photosensitivity — which matters unusually here, since sunlight is already a trigger
- Nausea and oesophageal irritation if taken lying down or without water
- Thrush
- Rarely, benign intracranial hypertension
Monitoring
A prescriber checks for interactions and, for longer courses, revisits whether the tablets are still needed rather than repeating indefinitely.
Worth knowing
- Tetracyclines are avoided in pregnancy and in young children because they affect developing teeth and bone
- Photosensitivity plus a condition triggered by sunlight is a combination worth planning around, not discovering in July
Pregnancy: Oral tetracyclines are avoided in pregnancy and while breastfeeding. Where systemic treatment is genuinely needed during pregnancy, a clinician will consider alternatives — this is precisely the situation in which the topical tier and azelaic acid carry the plan.
Why it sits where it does: It sits above the topicals because it accepts systemic exposure in exchange for reaching inflammation that creams have not controlled — and the low-dose version exists specifically so that trade is smaller than it used to be.
Prescription oral Low-dose oral isotretinoin
Systemic retinoid for refractory and early phymatous disease
Avoid in pregnancy
Low-dose oral isotretinoin
Systemic retinoid for refractory and early phymatous disease
Used off-label in rosacea, at doses well below those used for acne, for inflammatory disease that has not responded to anything else and for thickening caught before it becomes structural.
What it's called at the pharmacy
Generic name Low-dose oral isotretinoin
Sold as
- Prescribed generically and under several brand names. Its rosacea use is off-label in most markets — it is licensed for severe acne
Off-label prescribing is routine and lawful. It does mean the manufacturer's leaflet will describe acne rather than rosacea, which is worth knowing before reading it.
How it works
Shrinks sebaceous glands and reduces the sebaceous hyperplasia that underlies early phyma, alongside a broad anti-inflammatory effect. In rosacea the aim is control at a low dose rather than the cumulative-dose cure targeted in acne.
What the evidence says promising
Low-dose isotretinoin has trial support in refractory papulopustular rosacea and is a recognised option in current guidance for disease resistant to standard treatment, and for early phymatous change before fibrosis is established.
Typical course
Months at a low daily dose, under specialist supervision, with relapse after stopping more common in rosacea than in acne.
Commonly discussed side effects
- Dryness of lips, skin, eyes and nose — the eye dryness matters more here given how often rosacea already involves the eyes
- Raised blood lipids and liver enzymes
- Muscle aches
- Mood changes have been reported and are monitored
Monitoring
Blood tests before and during treatment, and in the case of anyone who can become pregnant, a strict pregnancy-prevention programme with regular testing.
Worth knowing
- Isotretinoin causes severe birth defects. The pregnancy-prevention requirements are not bureaucracy and are not negotiable
- It can worsen ocular dryness, which needs stating in a condition where the eyes are frequently involved already
Pregnancy: Absolutely contraindicated in pregnancy — isotretinoin is a potent teratogen, and prescribing is governed by formal pregnancy-prevention programmes requiring contraception and repeated testing before, during and after treatment.
Why it sits where it does: It sits near the top because it is the systemic option reached when the ordinary ladder has been climbed without success, and because in early thickening it is one of the few medical treatments with anything to offer before surgery becomes the answer.
Procedure Vascular laser and light
Pulsed dye laser, KTP and intense pulsed light
Individualized — ask a clinician
Vascular laser and light
Pulsed dye laser, KTP and intense pulsed light
The only thing on this page that removes a visible blood vessel. Everything else manages inflammation; this addresses the plumbing.
- Pulsed dye laser — The most-studied device for facial redness and thread veins.
- Potassium-titanyl-phosphate (KTP) laser — Targets discrete vessels precisely.
- Intense pulsed light — Broader wavelength coverage; useful for diffuse background redness.
How it works
Light at wavelengths absorbed by haemoglobin heats the blood inside a dilated vessel enough to damage its wall, and the body clears the collapsed vessel over the following weeks. Nothing applied to the surface of skin can accomplish this, which is the entire reason the procedure tier exists.
What the evidence says strong
Laser and light devices have consistent evidence for reducing telangiectasia and background erythema in rosacea, and a recent systematic review with network meta-analysis compared the available devices directly. They are the recommended approach for the vascular features that topical treatment does not reach.
Typical course
A series of two to four sessions several weeks apart, with maintenance every year or two as new vessels appear — because the underlying tendency has not been removed.
Commonly discussed side effects
- Bruising for up to a fortnight with pulsed dye laser at higher settings
- Swelling and redness for a few days
- Rarely, blistering, crusting or a change in pigment
- Post-inflammatory pigmentation, a greater risk in deeper skin tones
Worth knowing
- Device settings matter more than device brand, and both are downstream of who is holding it — practitioner experience is the variable that actually predicts the outcome
- Vessels recur; this is treatment rather than cure, and a clinic implying permanence is overselling
- Deeper skin tones need a practitioner experienced in treating them, because the settings that are safe differ
Pregnancy: Elective laser is generally deferred during pregnancy, mostly because there is no reason to accept any unknown for a cosmetic benefit that will still be available afterwards.
Why it sits where it does: It sits in the procedure tier not because it is a last resort but because it answers a different question from everything below it. Someone whose main problem is thread veins may reach this rung early, having correctly skipped drugs that were never going to help.
Procedure Phyma reshaping
Ablative laser, electrosurgery and surgical debulking
Individualized — ask a clinician
Phyma reshaping
Ablative laser, electrosurgery and surgical debulking
The answer to established thickening, and the point at which rosacea becomes a structural problem rather than an inflammatory one.
- Ablative CO2 or erbium laser — Reshapes thickened tissue layer by layer.
- Electrosurgical sculpting and dermabrasion — Long-established techniques, often used alongside laser.
- Surgical debulking — For substantial phyma, sometimes staged.
How it works
Physical removal and reshaping of overgrown sebaceous and fibrous tissue, allowing the surface to re-epithelialise over a restored contour. No medicine reverses fibrosis once it is laid down, which is why this tier exists at all.
What the evidence says strong
Ablative and surgical techniques are the established approach to phymatous rosacea in current guidance, with medical treatment reserved for the inflammatory component and for arresting progression before fibrosis is fixed.
Typical course
One or more sessions with a genuine recovery period of one to several weeks, followed by ongoing medical treatment to control what caused it.
Commonly discussed side effects
- A raw healing period requiring real aftercare
- Prolonged redness at the treated site
- Pigment change and scarring risk, higher in deeper skin tones
- Recurrence over years if the inflammatory disease is left untreated
Worth knowing
- Phyma is frequently and wrongly attributed to alcohol. That association is a myth, it is socially costly to the people who carry it, and correcting it is part of treating the condition
- Early thickening may respond to medical treatment; the window for that closes as fibrosis establishes, which is an argument for raising it early rather than waiting
Pregnancy: Elective reshaping is deferred during pregnancy. Phyma develops over years, so waiting costs little clinically.
Why it sits where it does: It sits at the top of the phymatous route because it is the only thing that restores contour, and it stays paired with medical treatment underneath it — reshaping without controlling the disease invites the same outcome again.
Procedure Ocular rosacea care
Ophthalmology and lid-margin management
Individualized — ask a clinician
Ocular rosacea care
Ophthalmology and lid-margin management
The part of rosacea a skincare page cannot help with, included because it is common, frequently missed, and the only component that can cost someone their sight.
- Lid hygiene and warm compresses — The foundation, and genuinely effective when done consistently.
- Preservative-free artificial tears — For the tear-film instability that produces the grittiness.
- Topical or oral antibiotics and anti-inflammatory eye drops — Prescribed and monitored by an eye clinician.
How it works
The same inflammatory process affects the meibomian glands along the lid margins, destabilising the oily layer of the tear film. The eye then dries, irritates and inflames, and in a minority the cornea becomes involved.
What the evidence says strong
Ocular involvement affects a substantial proportion of people with rosacea, often precedes cutaneous features, and is specifically addressed in current management guidance with referral advised where the cornea may be involved.
Typical course
Lid hygiene continues indefinitely; medical treatment is directed by an eye clinician and reviewed rather than repeated open-endedly.
Commonly discussed side effects
- Warm compresses and lid cleaning are tedious and abandonment is the usual failure
- Drops containing preservatives can worsen irritation with frequent use
Monitoring
An eye examination is what establishes whether the cornea is involved, and that determines everything about how urgently this is treated.
Worth knowing
- Ocular symptoms do not track skin severity — mild-looking skin can accompany significant eye disease
- Over-the-counter redness-relief eye drops constrict vessels and can rebound in the eye much as they do on the face
Pregnancy: Lid hygiene, compresses and preservative-free tears are unaffected by pregnancy. Any prescribed eye medicine is chosen with pregnancy in mind by the clinician prescribing it, and oral tetracyclines are avoided as they are elsewhere.
Why it sits where it does: It sits in its own route rather than on the skin ladder because it does not follow the same escalation, and because the trigger for acting on it is a symptom rather than a failed treatment.
On the horizon
Pipeline information current as of 2026-07-28
Only treatments in phase 3 trials, submitted to a regulator, or recently approved. Earlier-stage work is excluded deliberately: most of it does not arrive, and listing it converts a research pipeline into a promise.
This changes nothing about what to do now. Nothing in this section changes what is available or advisable today. It is here so that a reader knows what is moving, not so that anyone defers treatment waiting for it.
Recently arrived
Microencapsulated benzoyl peroxide 5% cream (2022). Benzoyl peroxide has always had activity relevant to rosacea and has always been too harsh for the skin that needs it. Holding it inside a slow-releasing silica shell was a formulation answer to a tolerability problem rather than a new molecule, which is a fair description of most genuine progress in this condition.
Minocycline 1.5% topical foam (2020). A tetracycline delivered to the skin rather than swallowed, which removes most of the systemic exposure that made long courses unattractive.
In late-stage development
The rosacea pipeline is quieter than the attention the condition receives would suggest, and the honest summary is that recent progress has come from reformulating known actives rather than from new mechanisms. The areas most likely to produce something are the vascular side — where topical treatment still cannot do what a laser does — and better-tolerated anti-inflammatory topicals. We list nothing speculative here on principle.
The other things people try
Rosacea attracts a large amount of hopeful treatment, some of it genuinely promising and some of it decorative. What follows is where the popular options actually stand — so that patience, and money, go where there is something to show for them.
- Botulinum toxin for flushing backed by smaller studies
Seventeen reports pooled in a 2023 review, mostly before-and-after and split-face rather than randomised, and consistently showing less flushing and less erythema. The catch is duration: symptoms tended to return at three to six months, so this is a repeating cost rather than a course. Promising enough to raise with a dermatologist, not established enough to sit on the ladder.
- Beta blockers for flushing backed by smaller studies
Carvedilol has the better modern showing of the older cardiovascular drugs tried here, with reported reductions in persistent erythema and flushing. It is a blood-pressure medicine used off-label, so it lowers blood pressure whether or not that was the point — prescriber territory entirely, and generally reserved for flushing severe enough to be disabling.
- An SSRI for redness nothing else touches backed by smaller studies
The most surprising entry on this list. A twelve-week randomised trial of paroxetine in refractory erythema beat placebo on facial redness, flushing and burning — which is more than any topical has managed against the flushing itself. One trial is one trial, and dizziness, nausea and lethargy were reported in the treated arm, so this belongs in a specialist conversation rather than a request at a routine appointment.
- Permethrin and older anti-mite creams backed by smaller studies
In a randomised comparison permethrin matched metronidazole gel on papules and cut mite counts further, while doing nothing at all for pustules, thread veins or thickening. Ivermectin has largely replaced it, but the result is worth knowing: it was among the first clean demonstrations that the mite is a real target rather than a bystander.
- Photodynamic therapy backed by smaller studies
Prospective series report meaningful clearance in inflammatory rosacea that has resisted standard treatment, including a light-plus-photosensitiser protocol published in 2024. Nothing has yet compared it against the treatments already known to work, protocols differ substantially between studies, and there is real downtime — so it sits as something a specialist may offer, not as a shortcut past the ladder.
- Probiotics and gut-directed therapy limited evidence
The gut–skin axis in rosacea is a serious research area rather than a wellness slogan: associations with small intestinal bacterial overgrowth and inflammatory bowel disease are consistently reported. What does not yet exist is a trial showing that a supplement changes a face. The biology is interesting; the product on the shelf is running ahead of it.
- Topical calcineurin inhibitors limited evidence
Small studies and case reports with inconsistent results, plus published reports of rosacea getting worse on them. Their occasional real use is in supervised withdrawal from a facial steroid, where the problem being solved is the steroid rather than the rosacea.
- Sulfur and sodium sulfacetamide limited evidence
Older than almost everything else here and thinner in modern evidence, though a controlled trial did show it reducing lesions. It survives as a tolerable fallback where the standard actives are not an option — and it smells exactly like what it is, which is most of the reason it fell out of fashion.
- LED masks, cooling rollers and capillary serums limited evidence
Cooling a flushing face feels wonderful and does nothing to a dilated vessel, which is a structural change in the wall of a blood vessel. No home device or topical has cleared telangiectasia in controlled study, and the money is better held toward a consultation with someone who owns a laser.
- Eliminating trigger foods wholesale limited evidence
Identifying personal triggers with a diary is genuinely first-line and genuinely useful. Taking avoidance to its logical end is not: a person who has removed alcohol, spice, heat, exercise, sunlight and hot drinks has a smaller life and, usually, the same face. Recognised as a harm of the trigger framing, and worth saying out loud.
Common questions
Is rosacea caused by drinking?
No, and this is the myth most worth dismantling because it is socially costly to the people carrying it. Alcohol is a vasodilator and a common trigger for flushing in people who already have rosacea, but it does not cause the condition. The association with a bulbous nose is even less deserved — phymatous change is a consequence of long-standing rosacea, not of alcohol intake, and plenty of people with phyma have never drunk at all.
Will anything get rid of the thread veins on my nose?
Nothing you can apply to the skin will, and that includes every serum, cream, LED device and cold roller marketed for the purpose. A visible vessel is a structural change, and the only treatments that clear one are vascular laser and intense pulsed light, performed in a clinic. That is worth knowing before rather than after spending a year on products — the money is better saved toward a consultation.
Why does my face get worse when I use products for sensitive skin?
Because 'for sensitive skin' is a marketing category rather than a formulation standard, and many products carrying it contain botanical extracts and essential oils that are among the more reliable irritants on reactive facial skin. Lavender, peppermint, menthol, camphor, witch hazel and citrus oils all appear regularly in soothing-branded products. Fragrance-free with a short ingredient list is a more reliable filter than any claim on the front of the box.
Can I use retinol if I have rosacea?
Sometimes, and rarely as a first move. Retinoids are irritating, and irritation is the mechanism that drives rosacea flares, so introducing one onto an unstable barrier usually goes badly. Where there is a genuine reason to use one — coexisting acne, or ageing concerns — it is generally introduced after rosacea is well controlled, at low strength, infrequently, buffered with moisturiser, and ideally with a clinician's input rather than experimentally.
My eyes have been gritty for months. Is that connected?
Quite possibly, and it is worth raising. Ocular involvement affects a large share of people with rosacea, frequently arrives before the skin changes, and is regularly put down to screens, air conditioning or allergies for years. Grittiness, burning, red lid margins and recurrent styes are the pattern. It needs a different set of measures from the face, and anything involving pain, light sensitivity or vision needs assessing the same day.
Is rosacea an autoimmune disease?
Not in the usual sense, though the answer is more interesting than a flat no. Rosacea involves a dysregulated innate immune response — the fast, non-specific arm of immunity — with abnormal production and processing of an antimicrobial peptide called cathelicidin. That is immune dysfunction, but it is not the adaptive, self-targeting process that defines autoimmune disease. There are epidemiological associations with several autoimmune conditions, which is a reason to mention rosacea to a doctor rather than a reason for alarm.
Does everyone with rosacea eventually get a bulbous nose?
No, and the old subtype framework unhelpfully implied otherwise by presenting rosacea as a progression through stages. Phymatous change affects a minority, develops over many years, and is substantially more common in men. Most people with rosacea never develop it. Being alert to early textural change is worthwhile because the medical window is real — but expecting it is neither accurate nor useful.
The other 133 questions
Everything that doesn’t fit on a therapy ladder — side effects, timelines, pregnancy, cost, the things people get told that aren’t true. Here are the ones asked most.
- Is this rosacea or just a face that goes red? Rosacea leaves redness behind. Ordinary flushing fades within minutes; rosacea builds a persistent background flush across the central face that never fully settles.
- Could my skincare routine be causing this? It cannot cause rosacea, but it very often sustains it — and in most people arriving with a red, stinging face, subtraction is the highest-yield first move.
- What actually causes rosacea? An over-reactive innate immune system plus dysregulated blood vessels and nerves in facial skin — inherited susceptibility, provoked by environment, not caused by anything you did.
- Does a red nose mean someone drinks too much? No. The association is a Victorian stereotype attached to phymatous rosacea, which occurs in people who have never drunk alcohol at all.
- My skin feels rough — should I exfoliate it? No — the roughness is barrier damage and inflammation, and exfoliation worsens both, which makes it the most common self-inflicted setback in rosacea.
- Which sunscreen won't sting my face? Mineral filters in a moisturising base, applied over your moisturiser. Zinc oxide and titanium dioxide are generally far better tolerated than chemical filters on rosacea skin.
- Which ingredients actually calm rosacea? Azelaic acid has the best over-the-counter evidence for inflammatory rosacea; niacinamide, ceramides and glycerin repair the barrier underneath it.
- Which products should I stop first? Foaming cleansers, exfoliants, alcohol-based toners, fragrance and anything that stings. Subtraction removes a meaningful share of the redness before any active is added.
- Why am I told never to use steroid cream on rosacea? Because it works briefly and then makes rosacea substantially worse, creating a dependence cycle that is difficult and unpleasant to escape.
- Why does everything sting on my face? Because the barrier is impaired and the sensory nerves are sensitised — stinging is a symptom of rosacea itself rather than proof you picked the wrong product.
- What are the eye symptoms of rosacea? Grittiness, burning, dryness, redness of the lid margins, recurrent styes and light sensitivity — and they can appear before any skin changes at all.
- What is the low-dose doxycycline for rosacea? A 40 mg modified-release dose set deliberately below antibacterial levels — it treats inflammation without exerting antibiotic pressure or selecting for resistance.
- Which rosacea treatments are safe in pregnancy? Topical azelaic acid and metronidazole are the usual first choices. Oral tetracyclines and isotretinoin are out, and topical ivermectin is not first-line.
- How do I spot rosacea on deeper skin? Go by warmth, swelling and symptoms rather than colour. Redness reads as dusky brown or violaceous, and papules plus burning are often the clearest signs.
- What can laser actually do for redness and veins? It is the only thing that removes visible vessels and fixed redness. Pulsed dye laser and IPL target haemoglobin, typically over three to five sessions.
Sources and further reading
The staging, escalation points, and therapy descriptions on this page are anchored to published clinical guidelines rather than editorial judgment.
What this page is built on
- Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee
- Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel
- Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments
The studies behind this pathway
Rosacea has no single national guideline in the way acne does, so this page is anchored to two consensus documents and built on the trials underneath them. Each link below was resolved against the journal record before it was published — a citation printed without one is a citation we could not confirm, not a link we forgot.
- Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee The phenotype-by-phenotype ordering of this whole page, and the treatment of skin care and photoprotection as management rather than as advice.
- Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel Why the four old subtypes were retired, and why the staging section describes features present instead of predicting a progression.
- Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments The comparative strength of the topical options against each other, which is what decides the order of the prescription topical step.
- Interventions for rosacea The older Cochrane assessment, still the reference point for metronidazole and the long-established treatments.
- Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies The trials behind ivermectin's place at the head of the prescription topical step, in participants averaging around thirty inflammatory lesions.
- Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea The two-mechanism argument on the ivermectin card — mite density falling and inflammatory markers falling in the same participants.
- Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials Why azelaic acid leads the over-the-counter step rather than sitting beside it as an also-ran.
- Topical metronidazole maintains remissions of rosacea The maintenance argument in the inflammatory route: people already cleared relapsed far less on a continued topical than on its vehicle.
- Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: Results of 2 phase 3, randomized, clinical trials Minocycline foam's inclusion as a genuine alternative rather than a footnote — two trials, more than fifteen hundred participants.
- Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Rosacea: Results From Two Phase III, Randomized, Vehicle-Controlled Trials The claim that encapsulation turned an active too harsh for rosacea skin into a tolerable one.
- Microencapsulated Benzoyl Peroxide for Rosacea in Context: A Review of the Current Treatment Landscape Where that formulation sits against everything else on the topical shelf, including its one-year follow-up.
- Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea The licensing evidence for a dose deliberately set below the level that suppresses bacteria.
- Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials The newest oral option on the ladder, tested against both placebo and the established low-dose doxycycline comparator.
- Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials How the two vasoconstrictors differ in practice, and why worsening redness is reported far less often with this one.
- Paradoxical Erythema Reaction of Long-term Topical Brimonidine Gel for the Treatment of Facial Erythema of Rosacea The rebound warning that belongs before a first application rather than after one.
- Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial The only randomized evidence that an oral drug reaches the flushing itself, and the reason it appears among the open questions rather than on a rung.
- Laser and energy-based devices for treating rosacea - a systematic review and network meta-analysis The device comparison behind the procedure step — which light suits diffuse colour and which suits a discrete vessel.
- Low-dose isotretinoin for the management of rosacea: A systematic review and meta-analysis The pooled case for using a systemic retinoid at doses well under acne dosing, and its adverse-event profile at that level.
- Treatment of ocular rosacea: a systematic review The response rates quoted in the eye route, across more than twelve hundred patients and every commonly used treatment.
- Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2) The first eye drop licensed against the mite itself, and why it appears as an option rather than a step.
- Diagnosis and Treatment of Rosacea Fulminans: A Comprehensive Review The description of the abrupt severe variant in the special-situations section — 135 reported cases, and how they were managed.
- Morbihan Disease Treatment: Two Case Reports and a Systematic Literature Review The persistent-swelling variant, including the finding that response tracked how long treatment ran rather than which drug was chosen.
- Managing a Burning Face: Clinical Manifestations and Therapeutic Approaches for Neurogenic Rosacea The burning-and-flushing variant that does not answer to anything on the main ladders, and what is used instead.
- The Efficacy and Safety of Botulinum Toxin A for the Treatment of Rosacea: A Systematic Review The honest placement of botulinum toxin: consistent reported benefit, weak study designs, and an effect that fades.
- Rosacea, microbiome and probiotics: the gut-skin axis What is actually established about the gut connection, against what is being sold on the strength of it.
- Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study An early demonstration that killing mites changes the bumps and touches nothing else — the mite argument before ivermectin existed.
- Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety The narrow-spectrum tetracycline listed among the oral alternatives, on pilot-level evidence.
- Carvedilol ameliorates persistent erythema of erythematotelangiectatic rosacea by regulating the status of anxiety/depression The beta-blocker entry among the open questions — real reported benefit for flushing, from a blood-pressure drug used off-label.
- Positive results of intense pulsed light-photodynamic therapy for moderate-to-severe rosacea: A prospective, single-arm study Photodynamic therapy's standing: encouraging single-arm results, no comparison against the treatments already known to work.
Everything on this page traces back to the sources below. Guidelines are written for clinicians and are dense, and they are also the most direct answer to why a ladder is ordered the way it is — worth reading in the original rather than through a summary.
Guidance and consensus
Rosacea has no single national guideline in the way acne or eczema do. What it has instead is expert consensus, and these two documents are what current practice rests on.
- Standard management options for rosacea: the 2019 update by the National Rosacea Society Expert Committee National Rosacea Society / Journal of the American Academy of Dermatology The document this page's structure follows most closely, organised by phenotype rather than subtype.
- Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel ROSCO panel / British Journal of Dermatology The international consensus that formalised the move away from subtypes.
Evidence reviews
Where the strength of each treatment is actually assessed, rather than asserted.
- Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments British Journal of Dermatology The most useful single source for comparing topical options against each other.
- Interventions for rosacea Cochrane Database of Systematic Reviews The Cochrane review; older, and still the reference point for several of the long-established treatments.
Patient information
Written to be read rather than decoded.
- Rosacea NHS (UK) Concise, and clear about what NHS treatment does and does not cover.
- Rosacea: patient resources National Rosacea Society (US) The patient arm of the organisation behind the management guidance above, including trigger survey data.
- Rosacea American Academy of Dermatology Signs, triggers and treatment overview written for the public.
Take the charts with you
Print exactly the piece you need. Each chart is one landscape page — no prose, no controls, sized to pin up or hand to someone — and the full document is the whole pathway as it reads on screen. Every printout carries the date, the source, and a line making clear it is not a diagnosis.
Printing happens in your browser. Your answers stay private — saved on this device, and to your free account when you're signed in.